BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: White PA, Johnson GE. Genetic toxicology at the crossroads-from qualitative hazard evaluation to quantitative risk assessment. Mutagenesis 2016;31:233-7. [PMID: 27000791 DOI: 10.1093/mutage/gew011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Zheng X, Wang F, Zhou J. A Hybrid Approach for Evaluating Faulty Behavior Risk of High-Risk Operations Using ANP and Evidence Theory. Mathematical Problems in Engineering 2017;2017:1-16. [DOI: 10.1155/2017/7908737] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
2 Smart DJ, Helbling FR, Verardo M, McHugh D, Vanscheeuwijck P. Mode-of-action analysis of the effects induced by nicotine in the in vitro micronucleus assay. Environ Mol Mutagen 2019;60:778-91. [PMID: 31294873 DOI: 10.1002/em.22314] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Pottenger LH, Boysen G, Brown K, Cadet J, Fuchs RP, Johnson GE, Swenberg JA. Understanding the importance of low-molecular weight (ethylene oxide- and propylene oxide-induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussions. Environ Mol Mutagen 2019;60:100-21. [PMID: 30536466 DOI: 10.1002/em.22248] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
4 Gibbons CF, Lebaron MJ. Applied genetic toxicology: From principles to practice: Editorial. Environ Mol Mutagen 2017;58:232-4. [DOI: 10.1002/em.22106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
5 Godschalk RWL, Yauk CL, van Benthem J, Douglas GR, Marchetti F. In utero Exposure to Genotoxicants Leading to Genetic Mosaicism: An Overlooked Window of Susceptibility in Genetic Toxicology Testing? Environ Mol Mutagen 2020;61:55-65. [PMID: 31743493 DOI: 10.1002/em.22347] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Lynch AM, Eastmond D, Elhajouji A, Froetschl R, Kirsch-Volders M, Marchetti F, Masumura K, Pacchierotti F, Schuler M, Tweats D. Targets and mechanisms of chemically induced aneuploidy. Part 1 of the report of the 2017 IWGT workgroup on assessing the risk of aneugens for carcinogenesis and hereditary diseases. Mutat Res Genet Toxicol Environ Mutagen 2019;847:403025. [PMID: 31699346 DOI: 10.1016/j.mrgentox.2019.02.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
7 Steiblen G, Benthem JV, Johnson G. Strategies in genotoxicology: Acceptance of innovative scientific methods in a regulatory context and from an industrial perspective. Mutat Res Genet Toxicol Environ Mutagen 2020;853:503171. [PMID: 32522346 DOI: 10.1016/j.mrgentox.2020.503171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
8 Meng F, Mei N, Yan J, Guo X, Richter PA, Chen T, De M. Comparative potency analysis of whole smoke solutions in the bacterial reverse mutation test. Mutagenesis 2021:geab021. [PMID: 34131742 DOI: 10.1093/mutage/geab021] [Reference Citation Analysis]
9 Pink M, Verma N, Schmitz-Spanke S. Benchmark dose analyses of toxic endpoints in lung cells provide sensitivity and toxicity ranking across metal oxide nanoparticles and give insights into the mode of action. Toxicol Lett 2020;331:218-26. [PMID: 32562635 DOI: 10.1016/j.toxlet.2020.06.012] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Johnson GE, Dobo K, Gollapudi B, Harvey J, Kenny J, Kenyon M, Lynch A, Minocherhomji S, Nicolette J, Thybaud V, Wheeldon R, Zeller A. Permitted daily exposure limits for noteworthy N-nitrosamines. Environ Mol Mutagen 2021;62:293-305. [PMID: 34089278 DOI: 10.1002/em.22446] [Reference Citation Analysis]
11 Seo JE, Davis K, Malhi P, He X, Bryant M, Talpos J, Burks S, Mei N, Guo X. Genotoxicity evaluation using primary hepatocytes isolated from rhesus macaque (Macaca mulatta). Toxicology 2021;462:152936. [PMID: 34509578 DOI: 10.1016/j.tox.2021.152936] [Reference Citation Analysis]
12 Heflich RH, Johnson GE, Zeller A, Marchetti F, Douglas GR, Witt KL, Gollapudi BB, White PA. Mutation as a Toxicological Endpoint for Regulatory Decision‐Making. Environ Mol Mutagen 2020;61:34-41. [DOI: 10.1002/em.22338] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
13 Guo X, Mei N. Benchmark Dose Modeling of In Vitro Genotoxicity Data: a Reanalysis. Toxicol Res 2018;34:303-10. [PMID: 30370005 DOI: 10.5487/TR.2018.34.4.303] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
14 White PA, Long AS, Johnson GE. Quantitative Interpretation of Genetic Toxicity Dose-Response Data for Risk Assessment and Regulatory Decision-Making: Current Status and Emerging Priorities. Environ Mol Mutagen 2020;61:66-83. [PMID: 31794061 DOI: 10.1002/em.22351] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
15 Wills JW, Johnson GE, Battaion HL, Slob W, White PA. Comparing BMD-derived genotoxic potency estimations across variants of the transgenic rodent gene mutation assay. Environ Mol Mutagen 2017;58:632-43. [PMID: 28945287 DOI: 10.1002/em.22137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
16 Li HH, Yauk CL, Chen R, Hyduke DR, Williams A, Frötschl R, Ellinger-Ziegelbauer H, Pettit S, Aubrecht J, Fornace AJ Jr. TGx-DDI, a Transcriptomic Biomarker for Genotoxicity Hazard Assessment of Pharmaceuticals and Environmental Chemicals. Front Big Data 2019;2:36. [PMID: 33693359 DOI: 10.3389/fdata.2019.00036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chen R, You X, Cao Y, Masumura K, Ando T, Hamada S, Horibata K, Wan J, Xi J, Zhang X, Honma M, Luan Y. Benchmark dose analysis of multiple genotoxicity endpoints in gpt delta mice exposed to aristolochic acid I. Mutagenesis 2021;36:87-94. [PMID: 33367723 DOI: 10.1093/mutage/geaa034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Klapacz J, Gollapudi BB. Considerations for the Use of Mutation as a Regulatory Endpoint in Risk Assessment. Environ Mol Mutagen 2020;61:84-93. [PMID: 31301246 DOI: 10.1002/em.22318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Buick JK, Williams A, Kuo B, Wills JW, Swartz CD, Recio L, Li HH, Fornace AJ Jr, Aubrecht J, Yauk CL. Integration of the TGx-28.65 genomic biomarker with the flow cytometry micronucleus test to assess the genotoxicity of disperse orange and 1,2,4-benzenetriol in human TK6 cells. Mutat Res 2017;806:51-62. [PMID: 29017062 DOI: 10.1016/j.mrfmmm.2017.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
20 Kuo B, Beal MA, Wills JW, White PA, Marchetti F, Nong A, Barton-Maclaren TS, Houck K, Yauk CL. Comprehensive interpretation of in vitro micronucleus test results for 292 chemicals: from hazard identification to risk assessment application. Arch Toxicol 2022. [PMID: 35445829 DOI: 10.1007/s00204-022-03286-2] [Reference Citation Analysis]